SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energys strong Q3 results and raised outlook have been overshadowed by a sharp post-earnings selloff, with traders citing negative cash flow, heavy investment needs, and a demanding valuation despite demand for data-center power. Bulls view the spending as investment in growth and are buying the dip, while skeptics question whether that growth will translate into cash.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is drawing attention amid a prolonged slide toward record lows, with traders debating whether the Trump-linked company has lasting value beyond political and crypto-related speculation. The discussion is largely bearish, citing weak business fundamentals and midterm-election risks, while a smaller group sees potential for a rebound on Trump-related headlines.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas Phase 3 melanoma-vaccine results with Keytruda, which showed a reduced risk of recurrence or death, have driven intense trading after the shares fell sharply in a sell-the-news reaction to leaked data following a major run-up. Traders are split between viewing the results as meaningful validation of the cancer-vaccine platform and arguing they fell short of lofty expectations or leave commercial questions unresolved; volatile rebounds and reversals are also a major focus.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics MSToronto presentationsparticularly preliminary Phase 1 azer-cel data in progressive MS with encouraging safety and early clinical signalsare driving attention, alongside long-term BRIUMVI and dosing updates. Traders praise the science but debate the muted stock reaction, noting azer-cel remains early-stage and pointing to BRIUMVI subcutaneous Phase 3 data and earnings as upcoming catalysts.

Icahn Enterprises LP is a holding company. It operates through the following segments: Investment, Automotive, Energy, Food Packaging, Real Estate, Home Fashion, Pharma, and Holding Company. The Investment segment consists of various private investment funds. The Automotive segment holds ownership in Icahn Automotive Group, LLC. The Energy segment refers to petroleum refining and marketing businesses. The Food Packaging segment involves the production and sale of cellulosic, fibrous, and plastic casings for the processed meat and poultry industry. The Real Estate segment offers rental real estate, property development, and resort activities. The Home Fashion segment deals with manufacturing, sourcing, marketing, distributing, and selling home fashion consumer products. The Pharma segments operate through Vivus, Inc., a specialized pharmaceutical company. The Holding Company segment manages acquisition and investment in operating businesses. The company was founded on February 17, 1987 and is headquartered in Sunny Isles Beach, FL.

Icahn Enterprises L P - Unit

Icahn Enterprises, L.P.

IEPs continued slide to deeply depressed levels has traders focused on concerns about a possible distribution cut, unit dilution, and Icahn Enterprises weakening value and management credibility. Some holders argue its CVR Energy stake and high short interest could support a rebound, while others see further downside risk and are waiting for earnings or clearer action from management.

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Phathom Pharmaceuticals Inc

BDR Pharmaceuticals is challenging the FDAs refusal to accept a generic application referencing VOQUEZNA, putting the drugs exclusivity through 2032 in focus and weighing on PHAT shares. Traders debate the risk of an earlier generic and a prolonged legal overhang against the view that the FDAs prior ruling supports Phathoms position and sales can keep growing during litigation.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as crude rallies on fears that escalating Iran and wider Middle East tensions could disrupt oil supplies and shipping, particularly through the Strait of Hormuz. Traders are split between riding the breakout and expecting a sharp pullback, with sentiment sensitive to shifting war and peace headlines.

Palo Alto Networks, is a cybersecurity company that provides cybersecurity platforms and services to enterprises, organizations, service providers, and government entities. Its offerings include network and AI security, cloud security, security operations, and identity security solutions. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto is drawing attention after a sharp rebound from recent lows, as traders connect renewed cybersecurity-sector strength to AI-driven threat concerns and newly disclosed PHP vulnerabilities. Bulls see durable security demand, while skeptics warn the rally may fade and cite stretched valuation.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFibers convertible senior-note offering has driven a sharp selloff, with traders concerned about potential dilution and the companys capital needs. Some see the financing as necessary to fund data-center expansion, while others worry that the capital structure and continued fundraising could weigh on shareholders.

Better Home & Finance Holding Co. engages in the provision of comprehensive homeownership services. It offers mortgage loans, real estate agent services, and title and homeowner's insurance services. The company was founded in 2014 and is headquartered in New York, NY.

Better Home & Finance Holding Co. - Ordinary Shares - Class A

Better Home & Finance Holding Co.

BETR is drawing attention for a sharp run that traders attribute to a potential short squeeze, citing the companys share repurchases, a small float, and reportedly scarce shares to borrow. The squeeze remains speculative: some traders expect further covering, while others point to fading volume and pullbacks as signs the rally may stall; weekly turnaround updates are another focus.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CYDY … 
As we&#39;re aware, AbbVie and Cytodyn have a license agreement, as noted in their SEC filing. I&#39;m curious about other companies that may be involved with Cytodyn in drug development within this group. 
 
Pfizer Inc. (U.S.), Abbvie Inc. (U.S.), Novartis AG (Switzerland), Amgen Inc. (U.S.), Boehringer Ingelheim International GmbH. (Germany), Merck &amp; Co Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceuticals Industries Ltd. (Israel), AstraZeneca (U.K.), Ampio Pharmaceuticals Inc. (U.S.), Lilly (U.S.), Zydus Group (India), Akorn, Incorporated (U.S.), DAIICHI SANKYO COMPANY, LIMITED (Japan) 
 
~  observer  ~  🐳

PureBullgogi

LIVIMMUNE Bound

Robert

Uebersax Peter

Mike

StockTwits Web

CytoDyn Inc

 … 
As we're aware, AbbVie and Cytodyn have a license agreement, as noted in their SEC filing. I'm curious about other companies that may be involved with Cytodyn in drug development within this group. 
 
Pfizer Inc. (U.S.), Abbvie Inc. (U.S.), Novartis AG (Switzerland), Amgen Inc. (U.S.), Boehringer Ingelheim International GmbH. (Germany), Merck & Co Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceuticals Industries Ltd. (Israel), AstraZeneca (U.K.), Ampio Pharmaceuticals Inc. (U.S.), Lilly (U.S.), Zydus Group (India), Akorn, Incorporated (U.S.), DAIICHI SANKYO COMPANY, LIMITED (Japan) 
 
~  observer  ~  🐳